Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8770412 | The Journal of Urology | 2018 | 30 Pages |
Abstract
The prostate score assay result is an independent predictor of adverse pathology findings in patients who were diagnosed with very low, low or intermediate risk prostate cancer in the setting of multiparametric magnetic resonance imaging fusion prostate biopsy. This assay can be useful as an independent technology or an adjunct technology to multiparametric magnetic resonance imaging to individualize risk stratification of low and intermediate risk prostate cancer.
Keywords
NCCNUniversity of California-Los AngelesPI-RADSPI-RADSv2UCLAmpMRIPSAADCMultiparametric MRIPCAProstate specific antigenMRIBiopsyMagnetic resonance imagingRadical prostatectomyProstate cancerNational Comprehensive Cancer Networkapparent diffusion coefficientProstatic neoplasmsGenomic Prostate ScoreGleason scorePathologyGenomicsProstate Imaging Reporting and Data System
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Amirali Salmasi, Jonathan Said, Alan W. Shindel, Pooria Khoshnoodi, Ely R. Felker, Anthony E. Jr., Tristan Grogan, Debbie McCullough, John Bennett, Helen Bailey, H. Jeffrey Lawrence, David A. Elashoff, Leonard S. Marks, Steven S. Raman, Phillip G. Febbo,